Welcome to our dedicated page for Nexgel Wt Exp 120126 news (Ticker: NXGLW), a resource for investors and traders seeking the latest updates and insights on Nexgel Wt Exp 120126 stock.
NexGel Inc (NXGLW) develops advanced hydrogel solutions for medical and cosmetic applications through proprietary electron beam cross-linking technology. This dedicated news hub provides investors and industry professionals with essential updates on the company’s innovations in wound care systems, transdermal delivery platforms, and material science breakthroughs.
Access timely announcements including regulatory milestones, strategic partnerships, product developments, and financial performance. Our curated collection ensures efficient tracking of NXGLW’s progress across key sectors: FDA-cleared medical devices, OTC hydrogel products, and custom manufacturing solutions for healthcare providers.
Discover press releases covering technical achievements, manufacturing expansions, and clinical application studies. All content is verified for accuracy and relevance to support informed analysis of NexGel’s market position in the competitive hydrogel industry.
Bookmark this page for centralized access to NXGLW’s material developments, presented with clarity for both technical experts and general investors. Regularly updated to reflect the company activities shaping next-generation hydrogel applications.
NEXGEL reported a 32% year-over-year revenue increase, reaching $2.05 million for 2022, driven by 34.7% growth in contract manufacturing and a 67.0% rise in branded consumer products. By year-end, the company had over $6.6 million in cash and securities, ensuring operational stability through 2025. Despite a slight revenue dip in Q4 2022, NEXGEL launched innovative products like Turfguard and expanded its joint ventures. The gross profit margin improved significantly to approximately 12.5%, a 3,100% increase from the previous year. However, a net loss of $4.75 million was reported for 2022, with expectations of reduced interest expenses in the coming year.
NEXGEL announced it will release its financial results for Q4 and full year 2022 on March 27, 2023, after market close.
The company specializes in high-water-content hydrogel products for healthcare and consumer applications, having developed over 200 unique formulations.
A conference call will follow the earnings release at 4:30 PM ET that day, accessible via live call or webcast. A replay will be available until April 3, 2023.
Investors can find more information on NEXGEL’s Investor Relations website.
NEXGEL, a provider of hydrogel products, has partnered with former lacrosse player Greg Gurenlian to address turf burn injuries through their innovative product, Turfguard. This hydrogel dressing aims to soothe turf burn while protecting athletic wounds, offering athletes a medical-grade solution to pain and infection risk. Gurenlian, with extensive experience in lacrosse, emphasizes the urgency of proper treatment for turf burn issues. Turfguard patches, FDA cleared, maintain a moist wound environment and offer cooling relief, now available for purchase on Amazon.com.
